Skip to Content

APO LMV 150 (Lamivudine 150 mg)

Pill with imprint APO LMV 150 is White, Four-sided and has been identified as Lamivudine 150 mg. It is supplied by Apotex Inc..

Lamivudine is used in the treatment of nonoccupational exposure; hepatitis b; occupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO LMV 150

Lamivudine 150 mg APO LMV 150
Lamivudine 150 mg APO LMV 150
Lamivudine 150 mg APO LMV 150 Front
Lamivudine 150 mg APO LMV 150 Back
Lamivudine 150 mg APO LMV 150

Lamivudine

Imprint:
APO LMV 150
Strength:
150 mg
Color:
White
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Inc.
Inactive Ingredients:
lactose anhydrous
crospovidone
silicon dioxide colloidal
hypromelloses
hydroxypropyl cellulose
magnesium stearate
polyethylene glycol
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00904-6583 Major Pharmaceuticals

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide